Second Sight Medical (EYES) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Second Sight Medical (EYES) PT Lowered to $2.50 at H.C. Wainwright
March 14, 2019 8:22 AM EDTH.C. Wainwright analyst Amit Dayal lowered the price target on Second Sight Medical (NASDAQ: EYES) to $2.50 (from $5.00) while maintaining a Buy rating.
Dayal commented, "We are lowering our price target on EYES to $2.50 from $5.00 to account for the company scaling... More
